Steven Damon News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Micron Biomedical, a life science company developing first-in-class dissolvable microarray-based products that simplify and improve the transport, storage, and administration of drugs and vaccines, today announced the appointment of global public health pioneer, Dr. Seth Berkley, as scientific advisor to the CEO. In this capacity, Dr. Berkley will guide the company's strategic manufacturing and supply chain efforts, as well as the go-to-market strategy including quality, distribution and pricing

Technology makes vaccines simpler to transport and administer but scaling up production has been a hurdle

The technology works by delivering the vaccine via dissolvable microneedles attached to the skin on a patch-like device

An Atlanta-based biotech company, Micron Biomedical announced last week that it has successfully concluded the first-ever clinical trial testing of a microarray injection-free vaccine on children as young as 9 months old. This clinical trial was funded by the Bill & Melinda Gates Foundation.

Bill Gates, the world-famous self-styled “philanthropist,” is about to make a boatload of cash off of a new vaccine delivery system one of his biotech firms has pioneered....